Clinical trial

A Phase 3 Trial in Advanced Epithelioid Mesothelioma

NCT07824986

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-12-01

PhasePHASE3

Study timeline

Study start (estimated)2026-12-01Date precision: day

Registry last updated2026-09-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pleural Mesotheliomaunresolved

Mesotheliomaunresolved

Interventions

VT3989DRUG

gemcitabineDRUG · verified · RxNorm: gemcitabine

VinorelbineDRUG · verified · RxNorm: vinorelbine

Sponsors & collaborators

Vivace Therapeutics, Inclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07824986 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.